Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome

Postgraduate Medical Journal

Volumn 72, Issue 849, 1996, Pages 419-422

  Sartorio, A ^a   Conti, A ^a   Ferrario, S ^c   Passini, E ^b   Re, T ^b   Ambrosi, B ^b  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale Caduti Bollatesi   (Italy)

Author keywords

Bone turnover; Cushing's sydrome

Indexed keywords

COLLAGEN TYPE 1; MARKER; OSTEOCALCIN; PEPTIDE;

ADULT; AGED; ARTICLE; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; CROSS LINKING; CUSHING SYNDROME; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MALE; OSSIFICATION; OSTEOLYSIS; PROTEIN BLOOD LEVEL; TREATMENT PLANNING;

EID: 0029934880     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.72.849.419     Document Type: Article

References (30)

1. Cushing H. The basophil adenomas of the pituitary body and their clinical manifestations. Bull Johns Hopkins Hosp 1932; 50: 137-95.
2. Kukreja SC, Bowser EN, Hargis GK, Henderson WJ, Williams GA. Mechanisms of glucocorticoid-induced osteopenia: role of parathyroid glands. Proc Soc Exp Biol Med 1976; 152: 358-61.
3. Burckhardt P. Corticosteroids and bone: a review. Horm Res 1984; 20: 59-64.
4. Petersen P, Jacobsen SEH. Cushing's disease presenting with severe osteoporosis. Acta Endocrinol (Copenh) 1986; 111: 168-73.
5. Reid IR. Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 1989; 30: 83-103.
6. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-64.
7. German C. Glucocorticoid induced osteoporosis. Clin Endocrinol 1994; 41: 273-4.
8. Lukert BP, Adams JS. Calcium and phosphorus homeostasis in man: effect of corticosteroid. Arch Intern Med 1976; 136: 1249-53.
9. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ. Histomorphomerric profile, pathophysiology and reversibility of corricosteroid-induced osteoporosis. Metab Bone Dis Rel Res 1979; 1: 303-19.
10. Meunier PJ, Bressot C. Endocrine influences on bone cells and bone remodeling evaluated by clinical histomorphometry. In: Parsons JA ed. Endocrinology of calcium metabolism. New York: Raven Press, 1982; pp 445-65.
11. Meunier PJ, Dempster W, Edouard C, Chapuy MC, Arlot M, Charhon S. Bone histomorphometry in corticosteroid induced osteoporosis in Cushing's syndrome. Adv Exp Med Biol 1984; 171: 191-200.
12. Gluck OS, Murphy WA, Hahn TJ, Hahn B. Bone loss in adults receiving alternate day glucocorticoid therapy. Arthritis Rheum 1981; 24: 892-8.
13. Lukert BP, Higgins JC, Stoskopf MM. Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 1986; 62: 1056-8.
14. Curtiss PH, Clark WS, Herndon CH. Vertebral fractures resulting from prolonged cortisone and corticotrophin therapy. JAMA 1954; 156: 467-9.
15. Howland WJ, Pugh DG, Sprague RG. Roentgenologic changes in the skeletal system in Cushing's syndrome. Radiology 1968; 71: 69-78.
16. Risteli L, Risteli J. Biochemical markers of bone metabolism. Ann Med 1993; 25: 385-93.
17. Sartorio A, Conti A, Monzani M. New markers of bone and collagen turnover in children and adults with growth hormone deficiency. Postgrad Med J 1993; 69: 846-50.
18. Sartorio A, Monzani M, Conti A, Casati G, Faglia G. Serum amino-terminal propeptide of type III procollagen (PIIINP) levels in patients with acromegaly before and after pituitary adenomectomy. Eur J Intern Med 1993; 4: 79-83.
19. Cryer PE, Kissane JM. Venebral compression fractures with accelerated bone turnover in a patient with Cushing's disease (clinicopathologic conference). Am J Med 1980; 68: 932-40.
20. Ambrosi B, Peverelli S, Passini E, et al. Abnormalities of endocrine function in patients with clinically "silent" adrenal mass. Eur J Endocrinol 1995; 132: 422-8.
21. Hough S, Teitelbaum SL, Bergfeld MA, Avioli LV. Isolated skeletal involvement in Cushing's syndrome: response to therapy. J Clin Endocrinol Metab 1981; 52: 1033-8.
22. Sartorio A, Ambrosi B, Colombo P, Morabito F, Faglia G. Osteocalcin levels in Cushing's disease before and after treatment. Horm Metab Res 1988; 20: 70.
23. Sartorio A, Ambrosi B, Conti A, Monzani M, Faglia G. Modifications in bone-Gla protein (BGP) and aminoterminal propeptide of type III procollagen (PIIINP) levels in one patient with Cushing's syndrome. Horm Metab Res 1991; 23: 247-9.
24. Piovesan A, Terzolo N, Reimondo G et al. Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm Metab Res 1994; 26: 234-7.
25. Gennari C, Imbimbo B, Montagnani M, Bernini M, Nardi P, Avioli LV. Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humans. Calcif Tissue Intern 1984; 36: 245-52.
26. Jowell PS, Epstein S, Fallon AID, Reinhardt TA, Ismail F. 1,25 Dihydroxyvitamin D3 modulates glucocorticoid induced alteration in serum bone Gla protein and bone histomorphometry. Endocrinology 1987; 120: 531-6.
27. Pastoureau P, Chavassieux P, Chapuy MC, Delmas PD, Meunier PJ. Glucocorticoid-induced osteoblastic depression in ewes. A biochemical and histological study. Bone Miner 1992; 17 (suppl 1): 158.
28. Wong GL. Basal activities and hormone responsiveness of osteoclast-like and osteoblast-like bone cells are regulated by glucocorticoids. J Biol Chem 1979; 254: 6337-40.
29. Nielsen HK, Thomsen K, Eriksen EF, Charles P, Storm T, Mosekilde L. The effects of high-dose glucocorticoid administration on serum bone gamma carboxyglutamic acid-containing protein, serum alkaline phosphatase and vitamin D metabolites in normal subjects. Bone Miner 1988; 4: 105-13.
30. Pocock NA, Eisman JA, Dunstan CR, Evans RA, Thomas DH, Huq NL. Recovery from steroid-induced osteoporosis. Ann Intern Med 1988; 107: 319-23.